About Us  |  Contact Us  |  Español
VNA of Care New England
VNA of Care New England

Economic Burden of Cancer Quantified in Europe

Cancer cost European Union €126 in 2009, with health care costs accounting for 40 percent
MONDAY, Oct. 14 (HealthDay News) -- The economic burden of cancer in the European Union (EU) was €126 billion in 2009, according to a study published online Oct. 14 in The Lancet Oncology.
Ramon Luengo-Fernandez, D.Phil., from the University of Oxford in the United Kingdom, and colleagues conducted a population-based cost analysis to quantify the economic burden of cancer in the EU. Aggregate data from morbidity, mortality, and health care resource use were obtained from international and national sources. Health care costs were estimated from expenditure on primary, outpatient, inpatient, and emergency setting care, and drug costs. In addition, costs of unpaid care and lost productivity were estimated.
The researchers found that, in 2009, cancer cost the EU €126 billion, with health care accounting for 40 percent of this cost. The health care costs were equivalent to €102 per citizen, but varied from €16 to €184 per person in Bulgaria and Luxembourg, respectively. The costs of productivity losses due to premature death and lost working days were €42.6 and 9.43 billion, respectively, while informal care costs were €23.2 billion. The economic costs were €18.8 billion for lung cancer, €15 billion for breast cancer, €13.1 billion for colorectal cancer, and €8.43 billion for prostate cancer.
"These data contribute to public health and policy intelligence, which is required to deliver affordable cancer care systems and inform effective public research funds allocation," the authors write.
The study was funded by Pfizer.
Abstract (http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(13)70442-X/abstract )Full Text (subscription or payment may be required) (http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(13)70442-X/fulltext )Editorial (subscription or payment may be required) (http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(13)70480-7/fulltext )
Health Headlines
FDA Approves HPV Test as Initial Screen for Cervical CancerView in a lightbox
FDA Proposes E-Cigarette RegulationsView in a lightbox
FDA Reconsiders Behavior-Modifying 'Shock Devices'View in a lightbox
Genetic Code of Tsetse Fly May Help Fight Sleeping SicknessView in a lightbox
Workplace Ladder Falls a Major Cause of Deaths, Injuries: CDCView in a lightbox
VNA of Care New England
© 2011 Site Index | Disclaimer | Legal Notices